According to GlobalData’s medical device pipeline database, 39 Dengue Virus devices are in various stages of development globally. GlobalData’s report Dengue Virus provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, ten are in active development, while the remaining 29 are in an inactive stage of development. There are six products in the early stages of development, and the remaining four are in the late stages of development.
In Vitro Diagnostics (IVD) include reagents, instruments and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. A Dengue Virus test is a blood test that can be used to diagnose dengue fever, a mosquito-borne illness. The test can detect the presence of the dengue virus in the blood, which can help to confirm a diagnosis.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Dengue Virus pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Dengue Virus devices. Overall, most of these Dengue Virus pipeline devices are being developed by private entities.
Key players involved in the active development of Dengue Virus include Roche Diagnostics International, University of Malaya, BluSense Diagnostics, Guangzhou Wondfo Biotech, HA TECH, InBios International, Labgene Biotech, Malaysian Bio-Diagnostics Research, McGill University and Mologic.
For a complete picture of the developmental pipeline for Dengue Virus devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.